Non invasive assessment of liver fibrosis

Annals of Transplantation

Volumn 13, Issue 2, 2008, Pages 5-11

  Yeshua, Hanni ^a,b   Oren, Ran ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Biomarkers; Fibroscan; Fibrotest; Liver biopsy; Liver diseases; Liver fibrosis

Indexed keywords

ALPHA 2 MACROGLOBULIN; BILIRUBIN; BIOLOGICAL MARKER; CHOLESTEROL; COLLAGEN; COLLAGEN TYPE 4; COLLAGEN TYPE 6; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACCURACY; BILIARY PERITONITIS; BLOOD LEVEL; CHRONIC DISEASE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ELASTOGRAPHY; GOLD STANDARD; HEMOPERITONEUM; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; NON INVASIVE PROCEDURE; OBSERVER VARIATION; PNEUMOTHORAX; POLICY; PROGNOSIS; REVIEW; SAMPLING ERROR; THROMBOCYTE COUNT; LIVER FUNCTION TEST; METABOLISM;

BIOLOGICAL MARKERS; ELASTICITY IMAGING TECHNIQUES; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS;

EID: 59649110954     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Niederau C, Lange S, Heintges T et al: Prognosis of chronic hepatitis. C: results of a large, prospective cohort study. Hepatology, 1998; 28 (6): 1687-1695
2. Friedman SL, Bansal MB: Reversal of hepatic fibrosis - fact or fantasy? Hepatology, 2006; 43(2 Suppl.1): S82-88
3. Bedossa P, Poynard T: An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology, 1996; 24: 289-293
4. Batts KP, Ludwig J: Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol, 1995; 19(12): 1409-1417
5. Goldin RD, Goldin JG, Burt AD et al: Intra-observer and interobserver variation in the histopathological assessment of chronic viral hepatitis. J Hepatol, 1996; 25: 649-654
6. Cadranel JF, Rufat P, Degos F: Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology, 2000; 32(3): 477-481
7. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology, 1994; 20: 15-20
8. Bedossa P, Dargère D, Paradis V: Sampling variability of liver fi brosis in chronic hepatitis C. Hepatology, 2003; 38: 1449-1457
9. Regev A, Berho M, Jeffers LJ et al: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol, 2002; 97: 2614-2618
10. Ratziu V, Charlotte F, Heurtier A et al, LIDO Study Group: Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology, 2005; 128(7): 1898-1906
11. Oberti F, Valsesia E, Pilette C et al: Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology, 1997; 113: 1609-1616
12. Sebastiani G, Alberti A: Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol, 2006; 12: 3682-3694
13. Castera L, Foucher J, Le Bail B et al: Prospective and independent validation of the lok index for prediction of cirrhosis in patients with chronic hepatitis c: comparison with fibroscan, fibrotest and APRI. J Hepatolog, 2006; 44(Suppl.2)
14. Cales P, Oberti F, Michalak S et al: A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology, 2005; 42: 1373-1381
15. Imbert-Bismut F, Ratziu V, Pieroni L et al: Biochemical markers of liver fi brosis in patients with hepatitis C virus infection: a prospective study. Lancet, 2001; 357: 1069-1075
16. Leroy V, Hilleret MN, Sturm N et al: Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol, 2007; 46: 775-782
17. Wai CT, Greenson JK, Fontana RJ et al: A simple noninvasive index can predict both signifi cant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 2003; 38: 518-526
18. Vallet-Pichard A, Mallet V, Nalpas B et al: FIB-4: an inexpensive and accurate marker of fi brosis in HCV infection.comparison with liver biopsy and fibrotest. Hepatology, 2007; 46: 32-36
19. Adams LA, Bulsara M, Rossi E et al: Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem, 2005; 51: 1867-1873
20. Halfon P, Bacq Y, De Muret A et al: Comparison of test performance profi le for blood tests of liver fi brosis in chronic hepatitis C. J Hepatol, 2007; 46: 395-402
21. Calès P, Halfon P, Bacq Y et al: Meta-analysis of blood scores for liver fibrosis in chronic hepatitis C. Hepatology, 2006; 44: 279A
22. Rosenberg WM, Voelker M, Thiel R et al, European Liver Fibrosis Group: Serum markers detect the presence of liver fi brosis: a cohort study. Gastroenterology, 2004; 127(6): 1704-1713
23. Guha IN, Parkes J, Roderick P et al: Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology, 2008; 47(2): 455-460
24. Lackner C, Struber G, Liegl B et al: Comparison and validation of simple noninvasive tests for rediction of fi brosis in chronic hepatitis C. Hepatology, 2005; 41(6): 1376-1382
25. Poynard T, Imbert-Bismut F, Munteanu M et al: Overview of the diagnostic value of biochemical markers of liver fi brosis (FibroTest, HCV-Fibrosure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol, 2004; 3(1): 8
26. Poynard T, Ratziu V, Naveau S et al: The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol, 2005; 4: 10
27. Poynard T, Morra R, Halfon P et al: Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol, 2007; 7: 40
28. Parkes J, Guha IN, Roderick P, Rosenberg W: Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol, 2006; 44(3): 462-474. Epub 2005 Nov 21
29. Poynard T, Munteanu M, Imbert-Bismut F et al: Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem, 2004; 50(8): 1344-1355. Epub 2004 Jun 10
30. Imbert-Bismut F, Ratziu V, Pieroni L et al, MULTIVIRC Group: Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet, 2001; 357(9262): 1069-1075
31. Shaheen AA, Myers RP: Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection. HIV Clin, 2008; 9(1): 43-51
32. Shaheen AA, Wan AF, Myers RP: Fibro test and FibroScan for the prediction of hepatitis C-related fi brosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol, 2007; 102(11): 2589-2 600. Epub 2007 Sep 10
33. Myers RP, Benhamou Y, Imbert-Bismut F et al: Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS, 2003; 17(5): 721-775
34. Poynard T, Zoulim F, Ratziu V et al: Longitudinal assessment of histology surrogate markers (Fibrotest- Actitest) during lamivudine therapy in patients with chronic hepatitis B infection. Am J Gast, 2005; 100: 1970-80
35. Naveau S, Raynard B, Ratziu V et al: Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol, 2005; 3: 167-174
36. Sandrin L, Fourquet B, Hasquenoph JM et al: Transient elastography: a new non invasive methods for assessment of hepatic fi brosis. Ultrasound in Medicine and Biology, 2003; 29: 1705-1713
37. Ziol M, Handra-Luca A, Kettaneh A et al: Non-invasive assessment of liver fibrosis by stiffness measurement: a prospective multicentre study in patients with chronic hepatitis C. Hepatology, 2005; 41(1): 48-54
38. Castera L, Vergniol J, Foucher J et al: Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology, 2005; 128: 343-350
39. Foucher J, Chanteloup E'Verginol J et al: Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study.Gut, 2006; 55(3): 403-408. Epub 2005 Jul 14
40. Colletta C, Smirne C, Fabris C et al: Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology, 2005; 42: 838-845
41. Yeshua H, Zelber-sagi S, Luria Y et al: Can fibroscan overcome the sampling error of liver biopsy? J Hepatolog, 2006; 44(Suppl.2)
42. Corpechot C, El Naggar A, Poujol-Robert A et al: Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology, 2006; 43(5): 1118-1124
43. de Lédinghen V, Douvin C, Kettaneh A et al: Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defi c Syndr, 2006; 41(2): 175-179
44. Ganne-Carrié N, Ziol M, de Ledinghen V et al: Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology, 2006; 44(6): 1511-1517
45. Vizzutti F, Arena U, Romanelli RG et al: Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology, 2007; 45(5): 1290-1297
46. Rockey DC: Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology, 2008; 134(1): 8-14
47. Carrión JA, Navasa M, Bosch J et al: Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver. Liver Transpl, 2006; 12(12): 1791-1798
48. Blasco A, Forns X, Carrión JA et al: Hepatic venous pressure gradient identifi es patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology, 2006; 43(3): 492-499
49. Arena U, Vizzutti F, Corti G et al: Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology, 2008; 47(2): 380-384
50. Castera L, Denis J, Babany G et al: Evolving practices of non-invasive markers of liver fibrosis in patients with chronic. hepatitis C in France: Time for new guidelines? J Hepatol, 2007; 46: 528-529